Diantha Duvall

Diantha Duvall, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Genocea Biosciences, Inc. and Curis Inc. In total, 5 filings cover trades dated from 15 March 2022 to 20 March 2026.

On the market, this insider has only sold: 3 sales, €2,912 in total. The rest of the record consists of 1 share grant.

On 23 March 2026 came the latest disclosure, a transaction in Curis Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.